Recent Advances on Drugs and Vaccines for COVID-19

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• The global Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a significant public health challenge.
• Despite extensive research, early-stage COVID-19 specific drugs have not met therapeutic expectations.
• Vaccines, by stimulating protective immunity, are considered the most promising strategy for managing COVID-19 infection.

Purpose of the Study:

• To identify the latest advancements in the research and development of COVID-19 drugs and vaccines.
• To provide a comprehensive reference for the prevention and treatment of COVID-19.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of clinical trial data for COVID-19 therapeutics and vaccines.
• Synthesis of information on drug efficacy and vaccine effectiveness.

Main Results:

• Significant progress has been made in vaccine development, offering a viable path towards immunity.
• Several antiviral therapies initially highlighted have demonstrated suboptimal curative effects.
• The landscape of COVID-19 treatment is evolving, with a continued focus on vaccine-induced immunity.

Conclusions:

• Vaccines remain the primary strategy for controlling COVID-19 due to the limitations of current antiviral therapies.
• Continued research and development are crucial for refining existing treatments and discovering novel therapeutic options.
• This review serves as a reference for understanding the current state of COVID-19 drug and vaccine development.